Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Transplant Associated Thrombotic Microangiopathy (TA-TMA) Commonly Occurs after Steroid-Refractory or Dependent Gastrointestinal (GI) Graft Versus Host Disease (GVHD) and Contributes to Post-Transplant Morbidity

Blood (2017) 130 (Supplement 1): 4483.

https://doi.org/10.1182/blood.V130.Suppl_1.4483.4483

Published: 2017

Journal Articles

Final Analysis of the Phase I/II Study of CC-486 (Oral Azacitidine) Maintenance Therapy after Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Marcos de Lima, MD, Betul Oran, MDMS, Richard E. Champlin, MD, Esperanza B. Papadopoulos, MD, Sergio A. Giralt, MD, Bart L. Scott, MD, Basem M. William, MD, Joel Hetzer, PhD, Becky Hubbell, PharmD, Barry S. Skikne, MD, Charles Craddock

Blood (2017) 130 (Supplement 1): 4512.

https://doi.org/10.1182/blood.V130.Suppl_1.4512.4512

Published: 2017

Journal Articles

Enhanced Spontaneous Anti-Tumor Cytotoxicity of Natural Killer Cells in Cutaneous T-Cell Lymphoma Patients

Bethany L Mundy-Bosse, PhD, Nathan Denlinger, MS, DO, Susan Huang, MD, Li Chen, Hsiaoyin Mao, David Kline, Eric McLaughlin, Youssef Youssef, Karen Young, Gerard Lozanski, MD, Aharon G. Freud, MD PhD, Pierluigi Porcu, MD, Basem M. William, MD, Michael A. Caligiuri, MD, Anjali Mishra, PhD

Blood (2017) 130 (Supplement 1): 2753.

https://doi.org/10.1182/blood.V130.Suppl_1.2753.2753

Published: 2017

Journal Articles

Psychosocial Risk Is Associated with High Readmission Rates and Increased Length of Stay for Patients Following Hematopoietic Stem Cell Transplantation

Daniel R Richardson, MD, Ying Huang, MA, MS, Patrick Elder, MS, Joanna Newlin, LISW, Cyndi Kirkendall, LISW, Steven M Devine, MD, Leslie A. Andritsos, MD, Don M Benson, MD PhD, William Blum, MD, Yvonne A Efebera, MD MPH, Craig C Hofmeister, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Heather L McGinty, PhD, Sam Penza, MD, Sumithra Vasu, MBBS, Basem M William, MD, Ashley E Rosko, MD

Blood (2016) 128 (22): 1241.

https://doi.org/10.1182/blood.V128.22.1241.1241

Published: 2016

Journal Articles

Impact of Human Leukocyte Antigen (HLA) Alleles on Outcomes of Allogeneic Transplantation (Allo-HCT) for B-Cell Non-Hodgkin Lymphomas (B-NHL); A CIBMTR Analysis

Basem M William, MD, Tao Wang, PhD, Michael D Haagenson, MS, Marcos J de Lima, MD, Marcelo Anibal Fernandez-Vina, PhD, Spellman Stephen, M.B.S., Stephanie J. Lee, MD, Brian T. Hill, MD PhD

Blood (2016) 128 (22): 3491.

https://doi.org/10.1182/blood.V128.22.3491.3491

Published: 2016

Journal Articles

Phase I Trial of the Base – Excision Repair Blocker Methoxyamine (TRC-102) Combined with Fludarabine in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Lymphoid Malignancies

Paolo Caimi, MD, Brenda Cooper, MD, Basem M. William, MD, Erica L Campagnaro, MD, Richard J. Creger, Pharm D, Manuel Afable, BSN, MD, Yan Xu, PhD, John Pink, PhD, Afshin Dowlati, Hillard M. Lazarus, MD, Marcos de Lima, MD, Stanton L. Gerson

Blood (2014) 124 (21): 4688.

https://doi.org/10.1182/blood.V124.21.4688.4688

Published: 2014

Journal Articles

Viral Insertion Safety in Patients with Glioblastoma Who Received a Novel Lentiviral MGMT-P140K Gene Therapy to Protect Bone Marrow from Chemotherapy: No Dominant Clonal Evolution Observed with Chemo-Selection

Hua Fung, Andrew E Sloan, Jane Reese, Basem M. William, MD, Karen Lingas, Lisa R Rogers, Heather Embree, Hillard M. Lazarus, Donna Kane, Boro Dropulic, Stanton L. Gerson

Blood (2014) 124 (21): 4801.

https://doi.org/10.1182/blood.V124.21.4801.4801

Published: 2014

Journal Articles

Brentuximab Vedotin (BV) Does Not Impair Autologous Peripheral Blood Stem Cell Mobilization and Collection in Refractory/Relapsed CD30+ Lymphoma Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplant (HDC-ASCT)

Manuel Afable, BSN, MD, Paolo F. Caimi, MD, Chitra Hosing, Marcos de Lima, MD, Issa F. Khouri, MD, Basem M. William, MD, Yago Nieto, MD PhD, Brenda W. Cooper, MD, Paolo Anderlini, MD, Erica L Campagnaro, MD, Stanton L. Gerson, Hillard M. Lazarus, MD, Richard E. Champlin, Uday R. Popat, MD

Blood (2014) 124 (21): 3854.

https://doi.org/10.1182/blood.V124.21.3854.3854

Published: 2014

Journal Articles

Increased Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma Patients Undergoing Therapy

Gayathri Ravi, MD, Brenda Cooper, MD, Erica L Campagnaro, MD, Basem M. William, MD, Richard J. Creger, Pharm D, Stanton L. Gerson, Marcos De Lima, MD, Hillard M. Lazarus, MD, Paolo Caimi, MD

Blood (2014) 124 (21): 5431.

https://doi.org/10.1182/blood.V124.21.5431.5431

Published: 2014

Journal Articles

All -Trans-Retinoic Acid (ATRA) Combined with Lithium As Treatment of Relapsed Non-Progranulocytic AML: Therapeutic Targeting Inhibition of the Glycogen Synthase Kinase 3-Beta (GSK3) Enzyme

Paolo Caimi, MD, Kalpana Gupta, PhD, Tammy Stefan, Brenda Cooper, MD, Basem M. William, MD, Erica L Campagnaro, MD, Richard J. Creger, Pharm D, Donna Kane, BSN, Stanton L. Gerson, Hillard M. Lazarus, MD, Marcos de Lima, MD, David N. Wald, MD PhD

Blood (2014) 124 (21): 5299.

https://doi.org/10.1182/blood.V124.21.5299.5299

Published: 2014

Journal Articles

Fingolimod Expands Human Umbilical Cord Blood Cells (UCB) in Vitro and Improves Engraftment Rate of Human UCB in Sublethally Irradiated NOD SCID Gamma (NSG) Mice

Basem M. William, MD, Stephen Moreton, Jane Reese, Pingfu Fu, Ph., D., Julia V. Busik, PhD, Marcos de Lima, MD, David N. Wald, MD PhD

Blood (2014) 124 (21): 2413.

https://doi.org/10.1182/blood.V124.21.2413.2413

Published: 2014

Journal Articles

Fasudil, a Rho-Associated Protein Kinase (ROCK) Inhibitor, Decreases Disease Burden in a Cbl/Cbl-b Deficiency-Driven Murine Model for Myeloproliferative Disorders

Basem M. William, MD, Dan Feng, Wei An, Scott Nadeau, Bhopal Mohapatra, Matt Storck, Hamid Band, MD PhD

Blood (2014) 124 (21): 4569.

https://doi.org/10.1182/blood.V124.21.4569.4569

Published: 2014

Journal Articles

CC-486 (Oral Azacitidine) Following Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Basem M. William, MD, Marcos de Lima, MD, Betul Oran, MD, Richard Champlin, MD, Esperanza B Papadopoulos, MD, Sergio Giralt, MD, Bart L. Scott, MD, Joel Hetzer, PhD, Xiwei Wang, PhD, Eric Laille, MS, Barry S. Skikne, MD, Charles Craddock, MDPhD

Blood (2014) 124 (21): 990.

https://doi.org/10.1182/blood.V124.21.990.990

Published: 2014

Journal Articles

Heparin-Induced Thrombocytopenia in Liver Transplant Recepients

Basem M. William, MD, MRCP, Sandeep K. Rajan, MD

Blood (2011) 118 (21): 4668.

https://doi.org/10.1182/blood.V118.21.4668.4668

Published: 2011

Journal Articles

Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Basem M. William, MD, MRCP, Maribeth Hohenstein, RN, BSN, OCN, Fausto R. Loberiza, Jr., MD, MS, Gabriel C. Caponetti, MD, R. Gregory Bociek, MD, Philip Bierman, MD, James O. Armitage, MD, Wing-Chung Chan, MD, Julie M. Vose, MD

Blood (2010) 116 (21): 288.

https://doi.org/10.1182/blood.V116.21.288.288

Published: 2010

Journal Articles

Curcumin Inhibits Proliferation of Leukemic Cells Expressing P210BCR-ABL or BCR-ABL-T315I and Prolongs Survival of Mice with B-Cell Acute Lymphoblastic Leukemia (B-ALL).

Basem M. William, MD, Ami Goodrich, Cong Peng, MS, Shaoguang Li, MD, PhD

Blood (2006) 108 (11): 1887.

https://doi.org/10.1182/blood.V108.11.1887.1887

Published: 2006

NARROW

Transplant Associated Thrombotic Microangiopathy (TA-TMA) Commonly Occurs after Steroid-Refractory or Dependent Gastrointestinal (GI) Graft Versus Host Disease (GVHD) and Contributes to Post-Transplant Morbidity

Final Analysis of the Phase I/II Study of CC-486 (Oral Azacitidine) Maintenance Therapy after Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Enhanced Spontaneous Anti-Tumor Cytotoxicity of Natural Killer Cells in Cutaneous T-Cell Lymphoma Patients

Psychosocial Risk Is Associated with High Readmission Rates and Increased Length of Stay for Patients Following Hematopoietic Stem Cell Transplantation

Impact of Human Leukocyte Antigen (HLA) Alleles on Outcomes of Allogeneic Transplantation (Allo-HCT) for B-Cell Non-Hodgkin Lymphomas (B-NHL); A CIBMTR Analysis

Phase I Trial of the Base – Excision Repair Blocker Methoxyamine (TRC-102) Combined with Fludarabine in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Lymphoid Malignancies

Viral Insertion Safety in Patients with Glioblastoma Who Received a Novel Lentiviral MGMT-P140K Gene Therapy to Protect Bone Marrow from Chemotherapy: No Dominant Clonal Evolution Observed with Chemo-Selection

Brentuximab Vedotin (BV) Does Not Impair Autologous Peripheral Blood Stem Cell Mobilization and Collection in Refractory/Relapsed CD30+ Lymphoma Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplant (HDC-ASCT)

Increased Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma Patients Undergoing Therapy

All -Trans-Retinoic Acid (ATRA) Combined with Lithium As Treatment of Relapsed Non-Progranulocytic AML: Therapeutic Targeting Inhibition of the Glycogen Synthase Kinase 3-Beta (GSK3) Enzyme

Fingolimod Expands Human Umbilical Cord Blood Cells (UCB) in Vitro and Improves Engraftment Rate of Human UCB in Sublethally Irradiated NOD SCID Gamma (NSG) Mice

Fasudil, a Rho-Associated Protein Kinase (ROCK) Inhibitor, Decreases Disease Burden in a Cbl/Cbl-b Deficiency-Driven Murine Model for Myeloproliferative Disorders

CC-486 (Oral Azacitidine) Following Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Heparin-Induced Thrombocytopenia in Liver Transplant Recepients

Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Curcumin Inhibits Proliferation of Leukemic Cells Expressing P210BCR-ABL or BCR-ABL-T315I and Prolongs Survival of Mice with B-Cell Acute Lymphoblastic Leukemia (B-ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only